| Name | Experiment | Genotype | Mutation | Stage | Tissue/organ | Treatment | Level | Time | replicates | |
|---|---|---|---|---|---|---|---|---|---|---|
| A17_LCO_WT- | CK dependent Rhizobium LC ...... | A17 | wild type genotype | Susceptible zone | E-MTAB-3007:A17 LCO WT002- | 3h | 3 | |||
| A17_LCO_WT+ | CK dependent Rhizobium LC ...... | A17 | wild type genotype | Susceptible zone | E-MTAB-3007:A17 LCO WT002+ | 3h | 3 | |||
| A17_noLCO_WT- | CK dependent Rhizobium LC ...... | A17 | wild type genotype | Susceptible zone | E-MTAB-3007:A17 noLCO WT003- | 3h | 3 | |||
| A17_noLCO_WT+ | CK dependent Rhizobium LC ...... | A17 | wild type genotype | Susceptible zone | E-MTAB-3007:A17 noLCO WT001+ | 3h | 3 | |||
| Mtcre1_LCO_WT- | CK dependent Rhizobium LC ...... | A17 | Mtcre1 mutant | Susceptible zone | E-MTAB-3007:Mtcre1 LCO WT003- | 3h | 3 | |||
| Mtcre1_LCO_WT+ | CK dependent Rhizobium LC ...... | A17 | Mtcre1 mutant | Susceptible zone | E-MTAB-3007:Mtcre1 LCO WT003+ | 3h | 3 | |||
| Mtcre1_noLCO_WT- | CK dependent Rhizobium LC ...... | A17 | Mtcre1 mutant | Susceptible zone | E-MTAB-3007:Mtcre1 noLCO WT001- | 3h | 3 | |||
| Mtcre1_noLCO_WT+ | CK dependent Rhizobium LC ...... | A17 | Mtcre1 mutant | Susceptible zone | E-MTAB-3007:Mtcre1 noLCO WT002+ | 3h | 3 | |||
| BAP3hr | Hormone treatment | A17 | 3 days after germination | root |
Cytokinin - 6-Benzylaminopurine; Medicago seedlings Roots |
100 nM 6-Benzylaminopurine | 3 hr | 3 | ||
| Control3hr | Hormone treatment | A17 | 3 days after germination | root |
DMSO Control; Medicago seedlings Roots |
DMSO Control | 3 hr | 3 | ||
| IAA3hr | Hormone treatment | A17 | 3 days after germination | root |
Auxin - Indole-3-acetic acid; Medicago seedlings Roots |
1 uM Indole-3-acetic acid | 3 hr | 3 |